Knight Therapeutics, Inc.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 21.91% vs -9.08% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -672.73% vs -79.44% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "107.40",
          "val2": "88.10",
          "chgp": "21.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "8.50",
          "val2": "6.00",
          "chgp": "41.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.40",
          "val2": "1.80",
          "chgp": "33.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-5.70",
          "val2": "-0.90",
          "chgp": "-533.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-12.60",
          "val2": "2.20",
          "chgp": "-672.73%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-34.20%",
          "val2": "-62.90%",
          "chgp": "2.87%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 13.13% vs 11.78% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 125.60% vs 43.81% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "371.30",
          "val2": "328.20",
          "chgp": "13.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "60.60",
          "val2": "56.80",
          "chgp": "6.69%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "9.20",
          "val2": "12.50",
          "chgp": "-26.40%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-11.60",
          "val2": "-13.50",
          "chgp": "14.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "4.30",
          "val2": "-16.80",
          "chgp": "125.60%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "20.20%",
          "val2": "19.60%",
          "chgp": "0.06%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

107.40

88.10

21.91%

Operating Profit (PBDIT) excl Other Income

8.50

6.00

41.67%

Interest

2.40

1.80

33.33%

Exceptional Items

-5.70

-0.90

-533.33%

Consolidate Net Profit

-12.60

2.20

-672.73%

Operating Profit Margin (Excl OI)

-34.20%

-62.90%

2.87%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is 21.91% vs -9.08% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -672.73% vs -79.44% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

371.30

328.20

13.13%

Operating Profit (PBDIT) excl Other Income

60.60

56.80

6.69%

Interest

9.20

12.50

-26.40%

Exceptional Items

-11.60

-13.50

14.07%

Consolidate Net Profit

4.30

-16.80

125.60%

Operating Profit Margin (Excl OI)

20.20%

19.60%

0.06%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 13.13% vs 11.78% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 125.60% vs 43.81% in Dec 2023

All Annual Results